Key facts
- This page summarizes Kevin Ali's Form 4 filing for Organon & Co. (OGN).
- 11 reported transactions and 5 derivative rows are listed below.
- Accepted by SEC: 02 Apr 2025, 17:32.
Kevin Ali - 31 Mar 2025 Form 4 Insider Report for Organon & Co. (OGN)
- Reporting relationship
- Chief Executive Officer, Director
- Issuer ticker
- OGN
- Reported as of
- 31 Mar 2025
- Net transaction value
- -$876,288
- SEC form
- 4
- Accepted by SEC
- 02 Apr 2025, 17:32:00 UTC
- Prior SEC filing
- 24 Feb 2025
- Next SEC filing
- 06 May 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Tarnetta V. Jones, as Attorney-in-Fact for Kevin Ali
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Kevin Ali filed Form 4 for Organon & Co. (OGN) on 02 Apr 2025.
Change
- Previous filing in this sequence was filed on 24 Feb 2025.
- Current net transaction value: -$876,288.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
OGN
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +48,758
- Change %
- +24%
- Price
- $0.000000
- Shares after
- 248,677
- Date
- 31 Mar 2025
- Ownership
- Direct
OGN
transaction
Common Stock
Tax liability
- Transaction value
- $391,248
- Shares
- -26,964
- Change %
- -11%
- Price
- $14.51
- Shares after
- 221,713
- Date
- 31 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
OGN
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +38,974
- Change %
- +18%
- Price
- $0.000000
- Shares after
- 260,687
- Date
- 31 Mar 2025
- Ownership
- Direct
OGN
transaction
Common Stock
Tax liability
- Transaction value
- $312,734
- Shares
- -21,553
- Change %
- -8.3%
- Price
- $14.51
- Shares after
- 239,134
- Date
- 31 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
OGN
transaction
Common Stock
Options Exercise
- Transaction value
- $0
- Shares
- +21,472
- Change %
- +9%
- Price
- $0.000000
- Shares after
- 260,606
- Date
- 31 Mar 2025
- Ownership
- Direct
OGN
transaction
Common Stock
Tax liability
- Transaction value
- $172,306
- Shares
- -11,875
- Change %
- -4.6%
- Price
- $14.51
- Shares after
- 248,731
- Date
- 31 Mar 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
OGN
transaction
Derivative
Stock Option (right to buy)
Award
- Transaction value
- $0
- Shares
- +1,072,607
- Change %
- Price
- $0.000000
- Shares after
- 1,072,607
- Date
- 31 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 1,072,607
- Exercise price
- $14.89
- Footnotes
- F2
OGN
transaction
Derivative
Restricted Stock Units
Award
- Transaction value
- $0
- Shares
- +218,267
- Change %
- Price
- $0.000000
- Shares after
- 218,267
- Date
- 31 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 218,267
- Exercise price
- Footnotes
- F3, F4
OGN
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -48,758
- Change %
- -33%
- Price
- $0.000000
- Shares after
- 97,518
- Date
- 31 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 48,758
- Exercise price
- Footnotes
- F3, F5
OGN
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -38,974
- Change %
- -50%
- Price
- $0.000000
- Shares after
- 38,974
- Date
- 31 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 38,974
- Exercise price
- Footnotes
- F3, F6
OGN
transaction
Derivative
Restricted Stock Units
Options Exercise
- Transaction value
- $0
- Shares
- -21,472
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 31 Mar 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 21,472
- Exercise price
- Footnotes
- F3, F7
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 7 footnotes
Footnote F1
This price is the closing market price of Organon & Co. ("Organon") common stock on Friday, March 28, 2025, as required by the plan under which the Restricted Stock Units ("RSU") were awarded.
Footnote F2
The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2026, March 31, 2027, and March 31, 2028.
Footnote F3
Each RSU converts into one share of Organon common stock.
Footnote F4
The Reporting Person was granted RSUs, which represent a contingent right to receive one share of Organon common stock for each RSU. On March 31, 2025, RSUs were granted and will vest in three equal installments on each of March 31, 2026, March 31, 2027, and March 31, 2028.
Footnote F5
On March 29, 2024, RSUs were granted and on March 29, 2025, one-third of these RSUs vested, with the remaining RSUs to vest on March 29, 2026, and March 29, 2027. Since the first anniversary of the date of grant was on Saturday, March 29, 2025, the vesting occurred on Monday, March 31, 2025, the next business day.
Footnote F6
On March 31, 2023, RSUs were awarded and on March 31, 2025, one-third of these RSUs vested with the remaining RSUs to vest on March 31, 2026.
Footnote F7
On March 31, 2022, RSUs were awarded and on March 31, 2025, the final third of these RSUs vested.